Several obstacles have hindered the successful transplantation of isle
ts of Langerhans to human patients in efforts to cure type I diabetes
mellitus. One problem is the necessity for short- and long-term storag
e of islets after isolation and before transplantation. Current long-t
erm storage methods, such as incubation in a physiological medium and
cryopreservation, are suboptimal, resulting in significant loss of via
ble islet mass or function. Better storage methods are needed, In this
study we examined the long-term storage of rat islets in macrobeads c
omposed of agarose and collagen, Islets isolated from Wistar-Furth rat
s were placed into macrobeads (1000 islets/macrobead) and maintained i
n culture for periods of up to 189 days at 37 degrees C. Insulin relea
sed from the cultured macrobeads remained constant for periods of at l
east 154 days. In one group, insulin release was 1050 mU/24 hr/4 beads
on day 3 and 1040 mU/24hr/4 beads on day 154. In another group, insul
in release was 1305 mU/24 hr/5 beads on day 17 and 1580 mU/24 hr/5 bea
ds on day 112. Xenotransplantation of Wistar Furth islet macrobeads, s
tored for 10 to 112 days at 37 degrees C, into 42 B6AF/1 mice with str
eptozotocin-induced diabetes resulted in a return to euglycemia in the
recipients within 24 hr. Thereafter, euglycemia was maintained for mo
re than 100 days in 32/42 of the recipients, and removal of the macrob
eads caused a return to hyperglycemia within 48 hr in all animals. In
addition, a group of 7 mice receiving macrobeads containing 1000 islet
s stored for 84 days had normal glucose tolerance tests (compared with
those of 7 nontreated, nontransplanted mice with streptozotocin-induc
ed diabetes and 7 normal mice), demonstrating that the islets in the m
acrobeads were functioning as they would in an intact pancreas. Finall
y, 5 macrobeads transplanted after initial storage of 112 days, remove
d from the first recipient after 100 days or more, stored again for 4
days in vitro, and retransplanted into 5 other diabetic mice also rest
ored and maintained euglycemia for at least 45 days. Our results indic
ate that collagen-agarose macrobeads are capable of preserving rat pan
creatic islets for extended periods without loss of in vitro insulin r
elease capability or ability to achieve and maintain euglycemia in viv
o, As such they should be useful for human islet transplantation effor
ts.